AMP-activated protein kinase promotes breast cancer stemness and drug resistance

Disease Models & Mechanisms

Sai Balaji Andugulapati¹  Mohini Lahiry¹  Ananthalakshmy Sundararaman²  Annapoorni Rangarajan² 

[1] Department of Molecular Reproduction, Development and Genetics;Indian Institute of Science, Bangalore 560012, India;

关键词: ampk;    anchorage deprivation;    stemness;    drug resistance;    twist;   

DOI  :  10.1242/dmm.049203

来源: DOAJ

【 摘 要 】

Breast cancer stem cells (BCSCs) are a major cause of therapy resistance and tumour progression. Currently, their regulation is not entirely understood. Previous work from our laboratory demonstrated a context-specific pro-tumorigenic role for AMP-activated protein kinase (AMPK) under anchorage-deprivation and mammosphere formation, which are hallmarks of BCSCs. Therefore, we investigated the role of AMPK in the maintenance of BCSC state/function. AMPK depletion reduces serial sphere formation in vitro and tumour initiation in vivo. Intriguingly, tumour-derived cell analysis using stem cell markers and functional assays revealed that AMPK is required for the maintenance of BCSC populations in vivo. AMPK promotes the expression of stemness genes such as Nanog, Sox2 and Bmi1 through the transcriptional upregulation of Twist via promoter acetylation. Further, AMPK-driven stemness plays a critical role in doxorubicin resistance. Significantly, AMPK activity increased after chemotherapy in patient-derived tumour samples alongside an increase in stemness markers. Importantly, AMPK depletion sensitises mouse tumours to doxorubicin treatment. Our work indicates that targeting of AMPK in conjunction with regular chemotherapy is likely to reduce the stem cell pool and improve chemosensitivity in breast cancers.

【 授权许可】

Unknown